<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23081" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nonimmune Hydrops Fetalis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vanaparthy</surname>
            <given-names>Rachana</given-names>
          </name>
          <aff>Oregon Health and Science University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vadakekut</surname>
            <given-names>Elsa S.</given-names>
          </name>
          <aff>American College of Osteopathic Obstetricians and Gynecologists</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahdy</surname>
            <given-names>Heba</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachana Vanaparthy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Elsa Vadakekut declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heba Mahdy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23081.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Most cases of hydrops fetalis are caused by nonimmune hydrops fetalis (NIHF), characterized by abnormal fluid accumulation in fetal compartments, including the peritoneal cavity, pleura, or generalized skin edema. Unlike immune hydrops fetalis, which primarily results from red blood cell alloimmunization, NIHF arises from various conditions that disrupt fluid regulation in the fetus. These conditions include cardiac abnormalities, infections, metabolic and hematologic disorders, and various genetic abnormalities.&#x000a0;The diagnosis of NIHF typically involves prenatal ultrasound, which identifies 2 or more abnormal fluid collections. Management strategies prioritize determining the underlying cause through diagnostic evaluations, such as genetic testing, amniocentesis, and fetal blood sampling. Genetic counseling is crucial, particularly for cases with an inherited recurrence risk. Treatment options for NIHF vary based on the specific etiology and may include intrauterine transfusions for fetal anemia, medications, drainage of pleural effusions, or specialized procedures. The prognosis varies widely depending on the cause, with some cases amenable to fetal therapy, whereas others may have a lethal outcome, requiring consideration of pregnancy termination or comfort care.&#x000a0;</p>
        <p>This activity reviews various treatment options tailored to specific etiologies of NIHF&#x000a0;and the implementation of appropriate management strategies, including the use of prenatal ultrasound, genetic testing, amniocentesis, and fetal blood sampling in the diagnostic process.&#x000a0;This activity provides clinicians with the knowledge and skills to accurately identify the underlying etiology of NIHF and emphasizes the role of the interprofessional healthcare team in optimizing patient outcomes, thereby promoting a comprehensive approach to managing the condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical and ultrasound features of nonimmune hydrops fetalis to facilitate early diagnosis.</p></list-item><list-item><p>Implement diagnostic protocols to determine the underlying cause of nonimmune hydrops fetalis, including amniocentesis and fetal blood sampling.</p></list-item><list-item><p>Select appropriate fetal therapy interventions, such as intrauterine transfusions or drainage procedures, based on the underlying condition.</p></list-item><list-item><p>Collaborate with an interprofessional healthcare team, including obstetricians, maternal-fetal medicine specialists, neonatologists, and genetic counselors, to optimize patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23081&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23081">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23081.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hydrops fetalis is characterized by abnormal interstitial fluid accumulation in fetal body compartments, such as the peritoneal cavity, pleura, and pericardium, or generalized skin edema. An alternative definition describes it as fluid accumulation in 2 fetal anatomical areas or as effusion in 1 site accompanied by anasarca.<xref ref-type="bibr" rid="article-23081.r1">[1]</xref>&#x000a0;Hydrops fetalis is typically classified into immune and nonimmune (NIHF) forms based on the underlying etiology. Immune hydrops fetalis, caused by red blood cell alloimmunization, has become rare due to the introduction of anti-D immune globulin prophylaxis.<xref ref-type="bibr" rid="article-23081.r2">[2]</xref>&#x000a0;In contrast, NIHF, which now accounts for 85% to 95% of hydrops cases, results from various conditions that disrupt fluid movement between vascular and interstitial compartments.<xref ref-type="bibr" rid="article-23081.r3">[3]</xref><xref ref-type="bibr" rid="article-23081.r4">[4]</xref></p>
        <p>Traditionally, according to the Society for Maternal-Fetal Medicine, hydrops fetalis is diagnosed during a prenatal ultrasound when 2 or more abnormal fluid collections are visualized, such as ascites, pericardial effusion, pleural effusion, or skin edema. However, some experts have adopted a&#x000a0;revised definition, diagnosing hydrops fetalis with the presence of a single fetal fluid collection, such as increased nuchal translucency thickness (&#x02265;3.5 mm) or cystic hygroma.<xref ref-type="bibr" rid="article-23081.r5">[5]</xref> With&#x000a0;the widespread use of routine prenatal ultrasounds to assess fetal anatomy, hydrops fetalis is often identified early in pregnancy. Most NIHF cases detected early in pregnancy are secondary to genetic or developmental disorders, while those identified after 22 weeks are more commonly associated with structural anomalies (eg, cardiovascular, urological, or gastrointestinal), metabolic aberrations, or infectious conditions.<xref ref-type="bibr" rid="article-23081.r3">[3]</xref>&#x000a0;</p>
        <p>Although NIHF is easily identified, determining the underlying etiology is challenging; therefore, a thorough diagnostic evaluation is essential for tailoring management appropriately.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;In fact, in 46% of cases, the etiology remains unknown.<xref ref-type="bibr" rid="article-23081.r7">[7]</xref> Complications of NIHF can include fetal or neonatal death, preterm delivery, and maternal mirror syndrome.<xref ref-type="bibr" rid="article-23081.r5">[5]</xref>&#x000a0;The&#x000a0;prognosis for patients with NIHF largely depends on the underlying cause.<xref ref-type="bibr" rid="article-23081.r8">[8]</xref> Therefore, an in-depth understanding of the evaluation and management of NIHF is crucial for improving patient outcomes.</p>
      </sec>
      <sec id="article-23081.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hydrops fetalis is associated with a broad spectrum of disorders, which are classified into 2 main categories&#x02014;immune and NIHF.</p>
        <p>
<bold>Immune Hydrops Fetalis</bold>
</p>
        <p>Immune hydrops fetalis is primarily caused by red blood cell alloimmunization due to Rh or ABO incompatibility. In Rh incompatibility, the fetal blood carries paternal Rh-positive antigens, which are recognized as foreign by the immune system of an Rh-negative mother, leading to the production of maternal anti-D antibodies. In subsequent pregnancies with Rh-positive fetuses, these antibodies can be produced in larger quantities as the maternal immune system retains a memory of the antigen. A similar mechanism occurs in ABO incompatibility, where maternal antibodies target fetal red blood cells carrying A or B antigens not present in the maternal blood. This immune response can lead to severe fetal or neonatal complications, including anemia, jaundice, hydrops fetalis, or kernicterus. However, with the introduction of anti-D immune globulin, immune hydrops fetalis has become rare.<xref ref-type="bibr" rid="article-23081.r9">[9]</xref><xref ref-type="bibr" rid="article-23081.r10">[10]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22739">Hemolytic Disease of the Fetus and Newborn</ext-link>," for more information.</p>
        <p>
<bold>Nonimmune Hydrops Fetalis</bold>
</p>
        <p>Currently, etiologies other than red blood cell alloimmunization account for approximately 85% to 95% of all cases of fetal hydrops.<xref ref-type="bibr" rid="article-23081.r3">[3]</xref><xref ref-type="bibr" rid="article-23081.r4">[4]</xref>&#x000a0;The most common underlying causes of NIHF are cardiovascular, chromosomal, and hematologic disorders.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref> However, NIHF can be a clinical feature of a wide range of conditions that disrupt the fetal body's ability to regulate interstitial fluid. The below-mentioned etiologies are associated with NIHF.</p>
        <p><bold>Cardiac disorders:</bold>&#x000a0;In approximately 20% of patients, an underlying cardiac condition is the cause of NIHF, typically due to a structural defect that leads to increased central venous pressure or diastolic ventricular dysfunction. Common conditions associated with this include paroxysmal supraventricular tachycardia, hypoplastic left heart syndrome, endocardial cushion defects, and congenital pulmonary airway malformation.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/26699">Paroxysmal Supraventricular Tachycardia</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/23285">Hypoplastic Left Heart Syndrome</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/17972">Atrioventricular Canal Defects</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20208">Congenital Pulmonary Airway Malformation</ext-link>," for more information on these conditions.</p>
        <p><bold>Chromosomal anomalies:</bold>&#x000a0;Genetic abnormalities are a common cause of NIHF. Although chromosomal disorders are often associated with cardiac or lymphatic defects, NIHF can also occur in syndromes without any associated structural abnormalities. Chromosomal anomalies frequently leading to NIHF include Turner, Down, and Edward syndromes, as well as other aneuploidies.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/30694">Turner Syndrome</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/20693">Down Syndrome</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20899">Edward Syndrome</ext-link>," for more information.</p>
        <p><bold>Lymphatic abnormalities:</bold>&#x000a0;Conditions that cause lymphatic dysfunction often present as NIHF, including congenital lymphatic dysplasia, lymphedema distichiasis syndrome, and Milroy disease.<xref ref-type="bibr" rid="article-23081.r5">[5]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/24553">Lymphangiomas</ext-link>," for more information.</p>
        <p><bold>Infections:</bold>&#x000a0;Infections such as parvovirus B19, cytomegalovirus, and syphilis in pregnant women are linked to anemia, anoxia, endothelial cell damage, and increased capillary permeability, all of which can lead to NIHF. Among these, parvovirus B19 is the most common infectious cause of NIHF.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/26717">Parvoviruses</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/20232">Cytomegalovirus</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/29822">Syphilis</ext-link>," for more information.</p>
        <p><bold>Metabolic diseases:</bold> Inborn metabolic disorders that lead to decreased red blood cell production, anemia, and reduced serum proteins, such as Niemann-Pick disease type C, Gaucher disease type 2, and &#x003b2;-glucuronidase enzyme deficiency, are associated with NIHF.<xref ref-type="bibr" rid="article-23081.r5">[5]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref></p>
        <p><bold>Fetal tumors:</bold> Fetal tumors such as sacrococcygeal teratoma, hepatic tumors, and neuroblastomas can cause NIHF due to increased cardiac demand or occupied space.<xref ref-type="bibr" rid="article-23081.r4">[4]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/25448">Myelomeningocele</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/22698">Congenital Hemangioma</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/25777">Neuroblastoma</ext-link>," for more information.</p>
        <p><bold>Renal and gastrointestinal conditions:</bold> Renal and gastrointestinal pathologies, such as congenital nephrotic syndrome, prune belly syndrome, volvulus, diaphragmatic hernia, and meconium peritonitis, can lead to decreased plasma oncotic pressure and are associated with NIHF.<xref ref-type="bibr" rid="article-23081.r11">[11]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/132261">Congenital Nephrotic Syndrome</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27911">Prune Belly Syndrome</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/31263">Volvulus</ext-link>," and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20476">Diaphragmatic Hernia</ext-link>," for more information.</p>
        <p><bold>Hematologic causes:</bold> Conditions such as congenital dyserythropoietic anemia, Fanconi anemia, &#x003b1;-thalassemia, hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency, and leukemias can lead to NIHF due to high cardiac output or fetal anemia.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r5">[5]</xref>&#x000a0;Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22315">Glucose-6-Phosphate Dehydrogenase Deficiency</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/29287">Hereditary Spherocytosis</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/17534">Fanconi Anemia</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22732">Alpha Thalassemia</ext-link>," "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28126">Pyruvate Kinase Deficiency</ext-link>,"&#x000a0;for more information.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref></p>
        <p><bold>Twin-twin transfusion</bold>
<bold>syndrome:</bold> NIHF is often observed in monochorionic multiple gestations complicated by twin-twin transfusion syndrome, primarily due to high cardiac output failure in the affected fetuses.<xref ref-type="bibr" rid="article-23081.r12">[12]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30697">Twin-Twin Transfusion Syndrome</ext-link>," for more information.</p>
      </sec>
      <sec id="article-23081.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>NIHF prevalence ranges from approximately 1 per 1700 to 3000 pregnancies overall; however, the incidence in live-born infants is about 1 in 4000 due to the high fetal mortality rate associated with some underlying etiologies and pregnancy terminations.<xref ref-type="bibr" rid="article-23081.r11">[11]</xref>&#x000a0;The&#x000a0;widespread use of anti-D immunoglobulin, available since 1968, has markedly reduced the prevalence of RhD alloimmunization and associated immune fetal hydrops. Consequently, NIHF now accounts for nearly 90% of hydrops fetalis cases.<xref ref-type="bibr" rid="article-23081.r13">[13]</xref></p>
      </sec>
      <sec id="article-23081.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hydrops fetalis can occur in conditions that either increase fluid transudation from the vascular compartment or delay lymphatic return to circulation. These mechanisms include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased capillary hydrostatic pressure</p>
          </list-item>
          <list-item>
            <p>Reduced plasma oncotic pressure</p>
          </list-item>
          <list-item>
            <p>Obstructed lymphatic flow</p>
          </list-item>
          <list-item>
            <p>Damaged peripheral capillaries&#x000a0;<xref ref-type="bibr" rid="article-23081.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>The exact pathophysiology of NIHF is not fully understood and largely depends on the specific fetal effects of the underlying etiology. For instance, decreased ventricular filling during diastole is a common mechanism in tachyarrhythmias, while increased central venous pressure, resulting from elevated right heart pressure, is typically observed in cardiac tumors and subendocardial fibroelastosis. Obstructed lymphatic drainage in the thoracic and abdominal cavities can occur due to masses such as cystic hygroma, as well as increased capillary permeability and decreased osmotic pressure associated with congenital infections and nephrosis. Consequently, management should primarily focus on addressing and reversing the underlying diseases.<xref ref-type="bibr" rid="article-23081.r14">[14]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref></p>
        <p>Hypoxia is another consequence of NIHF, leading to increased catecholamines and reduced hepatic and renal blood flow due to the redistribution of blood to the brain, heart, adrenals, and ductus venosus. This results in the activation of the renin-angiotensin system, increased antidiuretic hormone levels, and decreased albumin. These mechanisms elevate central venous pressure and impair lymphatic return to systemic circulation, exacerbating intravascular volume loss and resulting in severe and progressive edema in the fetus.<xref ref-type="bibr" rid="article-23081.r15">[15]</xref></p>
      </sec>
      <sec id="article-23081.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Maternal Clinical Features</bold>
</p>
        <p>NIHF is primarily diagnosed through fetal clinical features observed on ultrasound imaging. Maternal presentation is often asymptomatic; however, in cases of polyhydramnios or mirror syndrome, clinical findings may include uterine enlargement, headache, visual disturbances, shortness of breath, and oliguria.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref></p>
        <p>
<bold>Neonatal Clinical Features</bold>
</p>
        <p>Neonates with NIHF present with clinical findings similar to those observed on fetal ultrasound. However, intrauterine fetal demise and neonatal death are common. Surviving neonates may exhibit ascites, pleural effusion, and general edema.<xref ref-type="bibr" rid="article-23081.r16">[16]</xref> Clinical features can vary based on the underlying etiology and may include cyanosis due to cardiac disease, hypotonia from congenital myopathy or hypothyroidism, hepatomegaly, cardiomyopathy, facial dysmorphism indicative of a metabolic storage disease, and dermatitis associated with TORCH infections (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex).<xref ref-type="bibr" rid="article-23081.r17">[17]</xref><xref ref-type="bibr" rid="article-23081.r18">[18]</xref><xref ref-type="bibr" rid="article-23081.r19">[19]</xref><xref ref-type="bibr" rid="article-23081.r20">[20]</xref><xref ref-type="bibr" rid="article-23081.r21">[21]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/102378">TORCH Complex</ext-link>," for more information.</p>
      </sec>
      <sec id="article-23081.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Fetal Ultrasound Findings</bold>
</p>
        <p>The primary clinical criteria for diagnosing NIHF involve detecting 2 or more abnormal fetal fluid collections on fetal ultrasound. Common findings include pleural effusion, ascites, pericardial effusion, and generalized skin edema (eg, skin thickness &#x0003e;5 mm).<xref ref-type="bibr" rid="article-23081.r11">[11]</xref>&#x000a0;Additional features associated with NIHF may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Placentomegaly</p>
          </list-item>
          <list-item>
            <p>Polyhydramnios (Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27411">Polyhydramnios</ext-link>," for more information.)</p>
          </list-item>
          <list-item>
            <p>Hepatosplenomegaly</p>
          </list-item>
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Cystic hygroma (Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20214">Cystic Hygroma</ext-link>," for more information.)</p>
          </list-item>
          <list-item>
            <p>Chylothorax&#x000a0;<xref ref-type="bibr" rid="article-23081.r16">[44]</xref><xref ref-type="bibr" rid="article-23081.r23">[45]</xref></p>
          </list-item>
        </list>
        <p>Polyhydramnios and placentomegaly, typically defined as placental thickness&#x000a0;of 4 cm or more in the second trimester or 6 cm or more in the third trimester, are not part of the core ultrasound criteria for NIHF but are frequently observed.<xref ref-type="bibr" rid="article-23081.r22">[22]</xref> These&#x000a0;findings can occur alone or alongside other NIHF features. As many imaging characteristics of NIHF overlap with those of other conditions, it is crucial to consider differential diagnoses.<xref ref-type="bibr" rid="article-23081.r16">[16]</xref><xref ref-type="bibr" rid="article-23081.r23">[23]</xref> Furthermore, NIHF features may lead to secondary complications. For example, significant ascites can compress the bowel and lead to pulmonary hypoplasia.<xref ref-type="bibr" rid="article-23081.r24">[24]</xref>&#x000a0;Pleural&#x000a0;effusion may be unilateral or bilateral, potentially leading to respiratory distress, lung hypoplasia, and associated respiratory or circulatory complications that can affect prognosis. Additionally, placentomegaly and polyhydramnios have been linked to an increased risk of preterm delivery in some studies.<xref ref-type="bibr" rid="article-23081.r25">[25]</xref></p>
        <p>
<bold>Additional Diagnostic Studies&#x000a0;</bold>
</p>
        <p>As NIHF&#x000a0;is a symptom of various underlying conditions affecting the fetal body's fluid management, determining the etiology through diagnostic studies is essential. The underlying cause directly impacts symptom development and prognosis. When NIHF is identified incidentally on prenatal ultrasound, additional structural abnormalities should be investigated using ultrasound imaging and fetal echocardiogram, as these may indicate the underlying etiology, such as a fetal cardiac abnormality.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Fetal heart rate monitoring, umbilical artery pulsatility index, end-diastolic flow, and middle cerebral artery (MCA) Doppler assessment are also valuable for detecting underlying causes. An MCA Doppler peak systolic velocity greater than 1.5 is considered diagnostic of fetal anemia.<xref ref-type="bibr" rid="article-23081.r26">[26]</xref></p>
        <p>Red blood cell alloimmunization should be ruled out initially by confirming the maternal blood type and Rh antigen status and performing an antibody screen, typically included in routine prenatal laboratory studies.&#x000a0;Additional laboratory tests may be required to further investigate the etiology of NIHF, including a maternal complete blood count, Kleihauer-Betke stain, thyroid hormone levels, and tests for parvovirus B19 and TORCH titers.<xref ref-type="bibr" rid="article-23081.r22">[22]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref>&#x000a0;Genetic etiologies should be considered if RBC alloimmunization is excluded and no structural cause is identified. This involves offering fetal karyotyping, fluorescence in situ hybridization studies, exome sequencing, and chromosomal microarray analysis, typically via amniocentesis or fetal blood sampling procedures.<xref ref-type="bibr" rid="article-23081.r5">[5]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref></p>
      </sec>
      <sec id="article-23081.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The primary management approach for NIHF is tailored according to the underlying etiology and the gestational age at which hydrops manifest. Careful evaluation and monitoring, along with effective resuscitation techniques, are crucial for improving the survival rates of affected neonates. For pregnancies with a lethal etiology, options include pregnancy termination or supportive care.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref></p>
        <p>For underlying NIHF pathologies that are treatable, therapeutic strategies aim to address the specific etiology and may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intrauterine transfusions for&#x000a0;fetal anemia.</p>
          </list-item>
          <list-item>
            <p>Antiarrhythmic agents for fetal cardiac arrhythmias.</p>
          </list-item>
          <list-item>
            <p>Drain or shunt placement for pleural effusion or chylothorax.</p>
          </list-item>
          <list-item>
            <p>Corticosteroids for congenital pulmonary airway malformations.</p>
          </list-item>
          <list-item>
            <p>Fetal therapy with sympathomimetics for atrioventricular block with ventricular rates less than 55 bpm.</p>
          </list-item>
          <list-item>
            <p>Laser coagulation of placental vessel anastomoses in twin-twin transfusion syndrome.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref></p>
          </list-item>
        </list>
        <p>Clinicians must also consider antenatal and intrapartum management of the pregnancy, including fetal monitoring for signs of deterioration with antenatal testing, determining delivery indications and mode, ensuring availability of an appropriate facility for delivery and neonatal resuscitation, and consulting specialists (such as neonatal cardiologists and cardiovascular surgeons).<xref ref-type="bibr" rid="article-23081.r11">[11]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref>&#x000a0;Delivery considerations are influenced by several clinical factors. Generally, delivery is often reasonable for pregnancies with NIHF at 34 weeks or more gestational period, depending on the underlying etiology. In cases with NIHF and stable maternal-fetal conditions, delivery by 37 to 38 weeks may be considered if indications for earlier delivery or clinical worsening do not exist.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref></p>
        <p>Postnatal management of NIHF involves several critical steps, including initial resuscitation to stabilize the neonate and identifying and treating the underlying cause. Most infants with hydrops fetalis require endotracheal intubation due to respiratory depression. Procedures such as thoracentesis, paracentesis, and occasionally cardiocentesis may be necessary to manage pleural effusion, ascites, and pericardial effusion. A&#x000a0;blood transfusion may be required in cases of severe anemia.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref>&#x000a0;Despite aggressive treatment, survival rates can be as low as 10%, with survivors at risk for neurodevelopmental and cognitive deficits. The recurrence rate is notably high in mothers whose infants have chromosomal abnormalities or Rh incompatibility. Therefore, autopsies, including histopathologic evaluation, placental examination, and molecular and genetic studies, may be performed to determine the cause of NIHF.<xref ref-type="bibr" rid="article-23081.r27">[27]</xref></p>
      </sec>
      <sec id="article-23081.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Any potential etiology of NIHF should be considered in the differential diagnoses, as mentioned below. (Please refer to "<bold>Nonimmune Hydrops Fetalis</bold>" in the <bold>Etiology</bold>&#x000a0;section for more information.)</p>
        <list list-type="bullet">
          <list-item>
            <p>Neonatal hemochromatosis</p>
          </list-item>
          <list-item>
            <p>Congestive cardiac failure</p>
          </list-item>
          <list-item>
            <p>Twin-twin transfusion syndrome</p>
          </list-item>
          <list-item>
            <p>Hepatitis B</p>
          </list-item>
          <list-item>
            <p>Hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Hypernatremia</p>
          </list-item>
          <list-item>
            <p>Hypothrombinemia</p>
          </list-item>
          <list-item>
            <p>Maternal diabetes</p>
          </list-item>
          <list-item>
            <p>Fetal abdominal cysts</p>
          </list-item>
          <list-item>
            <p>Obstructed bowel</p>
          </list-item>
          <list-item>
            <p>Obstructed urinary system&#x000a0;<xref ref-type="bibr" rid="article-23081.r28">[28]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23081.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of hydrops fetalis primarily depends on the underlying cause, gestational age at diagnosis, timing of delivery, extent of fetal edema, and intrauterine interventions.<xref ref-type="bibr" rid="article-23081.r29">[29]</xref>&#x000a0;Neonates with thoracic causes and bronchopulmonary malformations generally have a better prognosis, whereas those with chromosomal abnormalities, structural defects, or genetic metabolic disorders often face a poorer prognosis.<xref ref-type="bibr" rid="article-23081.r30">[30]</xref></p>
        <p>Long-term survival in hydrops fetalis largely depends on the underlying disease, the effectiveness of fetal therapies to address hydrops, and the gestational age at delivery rather than the specific anatomical manifestations of hydrops. The cardiovascular profile score can be a useful prognostic indicator for fetuses with NIHF, particularly those with high cardiothoracic ratios. Patients with NIHF who receive fetal interventions for their underlying condition often experience improved survival, particularly when hydrops can be resolved without preterm delivery. Although specific physiological parameters, such as MCA peak systolic velocity, do not predict survival, the cardiovascular profile score is valuable for predicting outcomes, especially in cases with a high cardiothoracic ratio. Additionally, the observation that various disease processes and cardiac abnormalities can lead to the common finding of fluid in 2 compartments suggests an underlying fetal distress mechanism that remains to be fully understood.<xref ref-type="bibr" rid="article-23081.r4">[4]</xref></p>
      </sec>
      <sec id="article-23081.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The complications associated with hydrops fetalis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Spontaneous miscarriage</p>
          </list-item>
          <list-item>
            <p>Intrauterine fetal demise</p>
          </list-item>
          <list-item>
            <p>Preterm delivery</p>
          </list-item>
          <list-item>
            <p>Perinatal deaths</p>
          </list-item>
          <list-item>
            <p>Early neonatal deaths</p>
          </list-item>
        </list>
        <p>Infants who survive hydrops fetalis may experience complications such as appendiceal rupture, cystic hygroma, intestinal obstruction, and severe neurodevelopmental delay. The most serious maternal complication is mirror syndrome, where the mother exhibits symptoms similar to those of her hydropic fetus. Clinical features of mirror syndrome often overlap with preeclampsia and may include pulmonary edema, peripheral edema, headache, visual disturbances, oliguria, elevated uric acid and liver function tests, low platelet count, and anemia.<xref ref-type="bibr" rid="article-23081.r31">[31]</xref><xref ref-type="bibr" rid="article-23081.r32">[32]</xref></p>
      </sec>
      <sec id="article-23081.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient counseling on NIHF, including its prognosis and management strategies, is essential. For pregnancies with a lethal etiology, options such as pregnancy termination or supportive care should be discussed.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref>&#x000a0;Furthermore, patients should be informed about antenatal and intrapartum management, including fetal monitoring, delivery indications, delivery mode, delivery and neonatal resuscitation facility requirements, and the need for specialist consultation to facilitate shared decision-making.<xref ref-type="bibr" rid="article-23081.r11">[11]</xref><xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref></p>
        <p>Clinicians should ensure patients are informed about potential postpartum procedures, such as endotracheal intubation, thoracentesis, paracentesis, and blood transfusion, which may be necessary. Additionally, patients should be made aware of the possible outcomes for the neonate if survival occurs, including potential neurodevelopmental and cognitive defects. Counseling should also address the risk of NIHF recurrence, particularly in autosomal recessive disorders.<xref ref-type="bibr" rid="article-23081.r6">[6]</xref><xref ref-type="bibr" rid="article-23081.r22">[22]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23081.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Close collaboration among healthcare providers such as obstetricians, maternal-fetal medicine specialists, radiologists, neonatologists, nurses, and pharmacists, as well as social workers, is crucial in managing NIHF. The interprofessional healthcare team focuses on the well-being of both the mother and fetus, ensuring early detection of fetal hydrops symptoms through careful evaluation and monitoring. Pharmacists contribute by managing medications and educating patients, while nurses provide essential support and education to the woman and her family. They also facilitate follow-up care and timely reporting of changes. Social workers offer emotional and financial support and collaborate with the family on genetic consultations and future pregnancy planning. This coordinated approach enhances clinical outcomes and supports the emotional well-being of pregnant women and their families.</p>
      </sec>
      <sec id="article-23081.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23081&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23081">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/hydrops-fetalis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23081">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23081/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23081">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23081.s15">
        <title>References</title>
        <ref id="article-23081.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kontomanolis</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Fasoulakis</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Hydrops Fetalis and THE Parvovirus B-19.</article-title>
            <source>Curr Pediatr Rev</source>
            <year>2018</year>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>239</fpage>
            <page-range>239-252</page-range>
            <pub-id pub-id-type="pmid">30124157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e57</fpage>
            <page-range>e57-e70</page-range>
            <pub-id pub-id-type="pmid">28742673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kosinski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krajewski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wielgos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jezela-Stanek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nonimmune Hydrops Fetalis-Prenatal Diagnosis, Genetic Investigation, Outcomes and Literature Review.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Jun</month>
            <day>08</day>
            <volume>9</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32521801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derderian</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Jeanty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fleck</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Peyvandi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moon-Grady</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirose</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>The many faces of hydrops.</article-title>
            <source>J Pediatr Surg</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-4; discussion 54</page-range>
            <pub-id pub-id-type="pmid">25598092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sparks</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Lianoglou</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Adami</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Pluym</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Holliman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Downum</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Faubel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boe</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Jolley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Uy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Slavotinek</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Devine</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hodoglugil</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Van Ziffle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>ME</given-names>
              </name>
              <collab>University of California Fetal&#x02013;Maternal Consortium</collab>
              <collab>University of California, San Francisco Center for Maternal&#x02013;Fetal Precision Medicine</collab>
            </person-group>
            <article-title>Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.</article-title>
            <source>N Engl J Med</source>
            <year>2020</year>
            <month>Oct</month>
            <day>29</day>
            <volume>383</volume>
            <issue>18</issue>
            <fpage>1746</fpage>
            <page-range>1746-1756</page-range>
            <pub-id pub-id-type="pmid">33027564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Society for Maternal-Fetal Medicine (SMFM)</collab>
              <name>
                <surname>Norton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dashe</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>212</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-39</page-range>
            <pub-id pub-id-type="pmid">25557883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sparks</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Thao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lianoglou</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Boe</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Datkhaeva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Fratto</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Jolley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Mardy</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ngan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rangwala</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rottkamp</surname>
                <given-names>CAM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uy</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Valdez Lopez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>ME</given-names>
              </name>
              <collab>University of California Fetal&#x02013;Maternal Consortium (UCfC)</collab>
            </person-group>
            <article-title>Nonimmune hydrops fetalis: identifying the underlying genetic etiology.</article-title>
            <source>Genet Med</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>1339</fpage>
            <page-range>1339-1344</page-range>
            <pub-id pub-id-type="pmid">30410095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinn</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Valcarcel</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Makhamreh</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Al-Kouatly</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>SI</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of monogenic etiologies of nonimmune hydrops fetalis.</article-title>
            <source>Genet Med</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-12</page-range>
            <pub-id pub-id-type="pmid">33082562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Slaughter</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Maisels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watchko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Grout</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Bundy</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bogen</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Feldman-Winter</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Bhutani</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Maradiaga Panayotti</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Okechukwu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rappo</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.</article-title>
            <source>Pediatrics</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>150</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">35927462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Winter</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Kaminski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tjoa</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Oepkes</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.</article-title>
            <source>BMC Pregnancy Childbirth</source>
            <year>2023</year>
            <month>Jan</month>
            <day>07</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">36611144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swearingen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Leuthner</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Nonimmune Hydrops Fetalis.</article-title>
            <source>Clin Perinatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-121</page-range>
            <pub-id pub-id-type="pmid">32000919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Randenberg</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Nonimmune hydrops fetalis part I: etiology and pathophysiology.</article-title>
            <source>Neonatal Netw</source>
            <year>2010</year>
            <season>Sep-Oct</season>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>281</fpage>
            <page-range>281-95</page-range>
            <pub-id pub-id-type="pmid">20829175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steurer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Peyvandi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Jelliffe-Pawlowski</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Moon-Grady</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset.</article-title>
            <source>J Pediatr</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>187</volume>
            <fpage>182</fpage>
            <page-range>182-188.e3</page-range>
            <pub-id pub-id-type="pmid">28533037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apkon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of hydrops fetalis.</article-title>
            <source>Semin Perinatol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>437</fpage>
            <page-range>437-46</page-range>
            <pub-id pub-id-type="pmid">8822328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Faye-Petersen</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Pathology of the stillborn infant for the general pathologist: part 2.</article-title>
            <source>Adv Anat Pathol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-93</page-range>
            <pub-id pub-id-type="pmid">25664943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Survival of Hydrops Fetalis with and without Fetal Intervention.</article-title>
            <source>Children (Basel)</source>
            <year>2022</year>
            <month>Apr</month>
            <day>08</day>
            <volume>9</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35455574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knilans</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Cardiac abnormalities associated with hydrops fetalis.</article-title>
            <source>Semin Perinatol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>483</fpage>
            <page-range>483-92</page-range>
            <pub-id pub-id-type="pmid">8822332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afifi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Eyal</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hydrops fetalis associated with congenital myotonic dystrophy.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>166</volume>
            <issue>3</issue>
            <fpage>929</fpage>
            <page-range>929-30</page-range>
            <pub-id pub-id-type="pmid">1550167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narchi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypothyroidism and nonimmune hydrops fetalis: associated?</article-title>
            <source>Pediatrics</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>1416</fpage>
            <page-range>1416-7</page-range>
            <pub-id pub-id-type="pmid">10610498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lysosomal storage disease overview.</article-title>
            <source>Ann Transl Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>24</issue>
            <fpage>476</fpage>
            <pub-id pub-id-type="pmid">30740407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>KKY</given-names>
              </name>
              <name>
                <surname>Hon</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
              <name>
                <surname>Man</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Congenital infections in Hong Kong: an overview of TORCH.</article-title>
            <source>Hong Kong Med J</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-138</page-range>
            <pub-id pub-id-type="pmid">32245914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mardy</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Chetty</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Sparks</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>A system-based approach to the genetic etiologies of non-immune hydrops fetalis.</article-title>
            <source>Prenat Diagn</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>732</fpage>
            <page-range>732-750</page-range>
            <pub-id pub-id-type="pmid">31087399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Narasimhan</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Ku</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Sohaey</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fetal Hepatomegaly: Causes and Associations.</article-title>
            <source>Radiographics</source>
            <year>2020</year>
            <season>Mar-Apr</season>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>589</fpage>
            <page-range>589-604</page-range>
            <pub-id pub-id-type="pmid">32125959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Feldstein</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Revzin</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Moshiri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Role of Imaging in Obstetric Interventions: Criteria, Considerations, and Complications.</article-title>
            <source>Radiographics</source>
            <year>2021</year>
            <season>Jul-Aug</season>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>1243</fpage>
            <page-range>1243-1264</page-range>
            <pub-id pub-id-type="pmid">34115536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Sparks</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Jelin</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Derderian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jeanty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gosnell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mackenzie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?</article-title>
            <source>J Ultrasound Med</source>
            <year>2018</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>1185</fpage>
            <page-range>1185-1191</page-range>
            <pub-id pub-id-type="pmid">29076544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Women&#x02019;s Imaging:</collab>
              <name>
                <surname>Glanc</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nyberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Khati</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dudiak</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Henrichsen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Poder</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shipp</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Zelop</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> Multiple Gestations.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>11S</issue>
            <fpage>S476</fpage>
            <page-range>S476-S489</page-range>
            <pub-id pub-id-type="pmid">29101986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Chaves</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Romaguera</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>de la Guardia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses.</article-title>
            <source>Pediatr Dev Pathol</source>
            <year>2002</year>
            <season>Jul-Aug</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>365</fpage>
            <page-range>365-74</page-range>
            <pub-id pub-id-type="pmid">12016530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machin</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of hydrops fetalis.</article-title>
            <source>Am J Med Genet</source>
            <year>1981</year>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-50</page-range>
            <pub-id pub-id-type="pmid">6794370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>An</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features of Neonates with Hydrops Fetalis.</article-title>
            <source>Am J Perinatol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>13</issue>
            <fpage>1231</fpage>
            <page-range>1231-9</page-range>
            <pub-id pub-id-type="pmid">26070120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nassr</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ness</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hosseinzadeh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salmanian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Erfani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Welty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bateni</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Shamshirsaz</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Popek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ruano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Keswani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cass</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Olutoye</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Shamshirsaz</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis.</article-title>
            <source>Fetal Diagn Ther</source>
            <year>2018</year>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-128</page-range>
            <pub-id pub-id-type="pmid">28647738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebel</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Avery</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Broome</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Gregg</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Alan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mostafa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fetal peritonitis due to appendiceal rupture: a rare complication of hydrops.</article-title>
            <source>Fetal Pediatr Pathol</source>
            <year>2008</year>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>121</fpage>
            <page-range>121-5</page-range>
            <pub-id pub-id-type="pmid">18633765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23081.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meng</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases.</article-title>
            <source>Sci Rep</source>
            <year>2019</year>
            <month>Jul</month>
            <day>24</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>10726</fpage>
            <pub-id pub-id-type="pmid">31341179</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
